IP Library Assignment 056389/0859
Patent Assignment
Reel/Frame 056389/0859

Assignment of Assignor's Interest

Recorded: 2021-05-28 Pages: 3
Assignors
SAMPATH, DEEPAK
Executed: 2014-04-07
FAIRBROTHER, WAYNE JOHN
Executed: 2014-04-14
Assignee
GENENTECH, INC.
1 DNA WAY, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-4990
Covered Property (1)
Combination Therapy of a Type Ii Anti-CD20 Antibody with a Selective Bcl-2 Inhibitor
Application: 17/187,468 →
Publication: US 2021/0177838
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 28, 2021
From: ROCHE GLYCART AG
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 056389/0878 →
Assignment of Assignor's Interest May 28, 2021
From: KLEIN, CHRISTIAN
To: ROCHE GLYCART AG
Reel/Frame 056389/0882 →
Assignment of Assignor's Interest May 28, 2021
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 056389/0886 →
Assignment of Assignor's Interest May 28, 2021
From: GENENTECH, INC.
To: GENENTECH, INC.; ABBVIE INC.
Reel/Frame 056389/0896 →
Assignment of Assignor's Interest May 28, 2021
From: ROBERTS, ANDREW W.; SEYMOUR, JOHN F.
To: ABBVIE INC.
Reel/Frame 056389/0904 →
Assignment of Assignor's Interest May 28, 2021
From: HUMERICKHOUSE, ROD A.
To: ABBVIE INC.
Reel/Frame 056389/0920 →